MOESM3 of Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

Dong, Di; Zhang, Fan; Zhong, Lian-Zhen; Fang, Meng-Jie; Huang, Cheng-Long; Yao, Ji-Jin; Sun, Ying; Tian, Jie; Ma, Jun; Tang, Ling-Long

doi:10.6084/m9.figshare.10027352.v1

12916_2019_1422_MOESM3_ESM.docx (22.22 kB)

MOESM3 of Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

journal contribution

posted on 2019-10-23, 08:25 authored by Di Dong, Fan Zhang, Lian-Zhen Zhong, Meng-Jie Fang, Cheng-Long Huang, Ji-Jin Yao, Ying Sun, Jie Tian, Jun Ma, Ling-Long Tang

Additional file 3. Supplementary methods.

Funding

National Natural Science Foundation of China

History

Usage metrics

Keywords

Individualized imaging biomarker Induction chemotherapy Survival benefit Treatment decision Locoregionally advanced nasopharyngeal cancer

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM3 of Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

Funding

National Natural Science Foundation of China

History

Usage metrics

Categories

Keywords

Licence

Exports